| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cifra de Afaceri - Ron | - | 0 | 218.638 | 1.141.644 | 1.901.348 | 2.195.896 | 3.459.439 | 4.340.082 | 6.631.697 | 9.834.609 |
| Venituri Totale - Ron | - | 0 | 218.357 | 1.143.456 | 1.902.778 | 2.271.593 | 3.472.747 | 4.347.508 | 6.640.335 | 9.906.421 |
| Cheltuieli Totale - Ron | - | 2.328 | 137.080 | 601.542 | 1.026.582 | 1.491.741 | 1.793.583 | 2.378.930 | 3.887.546 | 5.491.981 |
| Profit/Pierdere Brut - Ron | - | -2.328 | 81.277 | 541.914 | 876.196 | 779.852 | 1.679.164 | 1.968.578 | 2.752.789 | 4.414.440 |
| Profit/Pierdere Net - Ron | - | -2.328 | 77.209 | 530.563 | 857.208 | 757.055 | 1.645.261 | 1.926.646 | 2.446.560 | 3.649.515 |
| Salariati | - | 0 | 2 | 3 | 7 | 6 | 7 | 0 | 12 | 20 |
Verifica rapoartele financiare pentru firma - Nyrvusano Pharmaceuticals Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Active Imobilizate | - | 783 | 33.987 | 76.887 | 122.726 | 188.179 | 118.810 | 67.424 | 272.235 | 227.657 |
| Active Circulante | - | 7.720 | 119.335 | 551.725 | 1.187.979 | 1.654.309 | 2.504.033 | 2.969.061 | 4.581.378 | 7.575.418 |
| Stocuri | - | 4.351 | 6.295 | 124.946 | 154.960 | 122.442 | 249.983 | 470.658 | 492.606 | 509.986 |
| Creante | - | 0 | 52.972 | 153.493 | 467.120 | 390.383 | 648.866 | 1.161.631 | 1.915.642 | 3.559.708 |
| Casa si conturi | - | 3.369 | 60.068 | 273.286 | 565.899 | 1.141.484 | 1.605.184 | 1.336.772 | 2.173.130 | 3.505.724 |
| Capitaluri Proprii | - | -2.118 | 75.191 | 568.125 | 1.238.144 | 1.806.778 | 2.503.964 | 2.874.820 | 4.533.337 | 6.593.942 |
| Capital Social | - | 210 | 310 | 310 | 310 | 310 | 620 | 620 | 620 | 620 |
| Datorii | - | 10.621 | 83.282 | 61.441 | 461.829 | 50.321 | 210.835 | 214.269 | 643.557 | 1.444.253 |
| Venituri in Avans | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Curs valutar - RON | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| CAEN Principal | "4690 - 4690" | |||||||||
| CAEN An Financiar |
4690
|
|||||||||
Comentarii - Nyrvusano Pharmaceuticals Srl